BRAINEVER
Business purpose.
Tant en France qu'à l'étranger: la recherche, le développement et la commercialisation de traitements thérapeutique des pathologies du système nerveux central; la création, l'acquisition, la location, la prise en location-gérance de tous fonds de commerce, la prise à bail, l'installation de tous établissements, fonds de commerce, usines ateliers, se rapportant à l'une ou l'autre des activités spécifiées; la prise, l'acquisition, l'exploitation ou la cession de tous procédés ou brevets concernant ces activités. La participation directe ou indirecte de la société dans toutes opérations financières, immobilières, ou mobilières et dans toutes entreprises commerciales ou industrielles pouvant se rattacher à l'objet social ou à tout objet similaire ou connexe de nature à favoriser son extension ou son développement.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- 10 to 19 employees
- Created
- 26 Mar 2015
- Share capital
- 60,269.02 EUR
- Registered with the trade register
- 31 Mar 2015
- Financial year end
- 31/12
- Establishments
- 1
Directors
- ALAIN LOUIS Prochiantz 77 years old, 12/1948 Administrateur
- BJ HOLDING Administrateur
- LNE SM HOLDING Administrateur
- IBIONEXT Administrateur
- DELOITTE & ASSOCIES Commissaire aux comptes titulaire
- Bernard Jacques Alexandre Gilly 69 years old, 03/1957 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- BIOMAGE via Bernard Jacques Alexandre Gilly
- EYE TECH CARE via Bernard Jacques Alexandre Gilly
- CHRONOLIFE via Bernard Jacques Alexandre Gilly
- B-GAME via Bernard Jacques Alexandre Gilly
- SCI NODANA via Bernard Jacques Alexandre Gilly
- BRAINEVER INVEST via Bernard Jacques Alexandre Gilly
Other companies at the same address
274 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
21 / 100 E
Confidence: medium · computed on the financial year ended 31 Dec 2024
- Equity to assets (-30.9 %)
- 0.0 out of 30
- EBITDA margin (-208.3 %)
- 0.0 out of 25
- Liquidity (101.3 %)
- 3.6 out of 20
- Debt (-109.6 %)
- 15.0 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
100 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (11.7 years)
- 20.0 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2024 | 0 € | — | -2,835,459 € | -2,076,532 € |
| 31 Dec 2023 | 0 € | — | -4,913,537 € | -4,618,693 € |
| 31 Dec 2022 | 0 € | — | -6,206,005 € | -4,576,216 € |
| 31 Dec 2021 | 0 € | — | -5,446,153 € | -3,935,308 € |
| 31 Dec 2020 | 0 € | — | -4,443,307 € | -3,171,639 € |
| 31 Dec 2019 | 0 € | — | -5,187,613 € | -4,106,201 € |
| 31 Dec 2018 | 0 € | — | -3,704,432 € | -2,945,437 € |
| 31 Dec 2017 | 0 € | — | -1,361,560 € | -1,028,120 € |
| 31 Dec 2016 | 0 € | first year on record | -648,187 € | -667,295 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.
IDCC 0176 · repealed · 1 establishment · declared in August 2026
Legal notices
-
Amendment 19 Jun 2026
- Court :
- Greffe du Tribunal des Activités Economiques de Paris
- Amendment :
- modification survenue sur le capital (augmentation)
BODACC B n 20260115, annonce n 2295 · Proof of publication (PDF)
-
Amendment 10 Feb 2026
- Court :
- Greffe du Tribunal des Activités Economiques de Paris
- Amendment :
- modification survenue sur le capital (augmentation) et l'administration
BODACC B n 20260027, annonce n 5587 · Proof of publication (PDF)
-
Filing of accounts 3 Sep 2025
- Court :
- Greffe du Tribunal des Activités Economiques de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250168, annonce n 4669 · Proof of publication (PDF)
-
Amendment 21 May 2025
- Court :
- Greffe du Tribunal des Activités Economiques de Paris
- Amendment :
- modification survenue sur le capital (augmentation)
BODACC B n 20250097, annonce n 1447 · Proof of publication (PDF)
-
Amendment 2 Oct 2024
- Court :
- Greffe du Tribunal de Commerce de Paris
- Amendment :
- modification survenue sur le capital (augmentation) et l'administration
BODACC B n 20240191, annonce n 1891 · Proof of publication (PDF)
-
Filing of accounts 12 Sep 2024
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240177, annonce n 7393 · Proof of publication (PDF)
-
Filing of accounts 27 Feb 2024
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20240040, annonce n 4270 · Proof of publication (PDF)
-
Filing of accounts 21 Feb 2024
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20240036, annonce n 3842 · Proof of publication (PDF)
-
Filing of accounts 23 Aug 2022
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20220162, annonce n 3898 · Proof of publication (PDF)
-
Filing of accounts 17 Aug 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2020
BODACC C n 20210159, annonce n 4588 · Proof of publication (PDF)
-
Amendment 12 Aug 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Amendment :
- modification survenue sur l'administration
BODACC B n 20210156, annonce n 2136 · Proof of publication (PDF)
-
Filing of accounts 19 Nov 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2019
BODACC C n 20200225, annonce n 12381 · Proof of publication (PDF)
-
Amendment 23 Oct 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Amendment :
- modification survenue sur le capital (augmentation)
BODACC B n 20190205, annonce n 1152 · Proof of publication (PDF)
-
Amendment 16 Aug 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Amendment :
- modification survenue sur l'administration
BODACC B n 20190157, annonce n 2129 · Proof of publication (PDF)
-
Filing of accounts 9 Aug 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2018
BODACC C n 20190153, annonce n 5373 · Proof of publication (PDF)
Filings and annual accounts as PDF →
Filings and accounts
- Formality 30 Jan 2026
- Formality 12 May 2025
Change history
- Appointed: Administrateur 9 Oct 2026
- Appointed: Administrateur 9 Oct 2026
- Appointed: Administrateur 9 Oct 2026
- Appointed: Commissaire aux comptes titulaire 9 Oct 2026
- Appointed: Administrateur 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Share capital changed from 21,400 € to 38,500 € 3 Oct 2026
- Share capital changed from 38,500 € to 21,400 € 3 Oct 2026
- Share capital changed from 47,329 € to 38,500 € 3 Oct 2026
- Share capital changed from 49,019.02 € to 47,329 € 2 Oct 2026
- Share capital changed from 70,269.02 € to 49,019.02 € 2 Oct 2026
- Registered office: 74 rue du Faubourg Saint-Antoine 75012 Paris 1 Oct 2026
- Share capital changed from 60,269.02 € to 70,269.02 € 1 Oct 2026
- Share capital: 60,269.02 € 1 Oct 2026
Frequently asked questions about BRAINEVER
- What is the SIREN number of BRAINEVER?
- The SIREN number of BRAINEVER is 810542506. Its intra-community VAT number is FR05810542506.
- Where is the head office of BRAINEVER?
- Head office address: 74 RUE DU FBG ST ANTOINE, 75012 PARIS 12.
- When was BRAINEVER founded?
- BRAINEVER was founded on 26 Mar 2015.
- What does BRAINEVER do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Who runs BRAINEVER?
- The officers listed in the register are ALAIN LOUIS Prochiantz (Administrateur), BJ HOLDING (Administrateur), LNE SM HOLDING (Administrateur).
- What is the revenue of BRAINEVER?
- The latest published revenue is 0 €, for the 2024 financial year.
- How many employees does BRAINEVER have?
- The declared headcount is 10 to 19 employees. Insee data for 2024.
- Is BRAINEVER subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.